Enavant LAFK9 Tablets contain a patented combination of Lactoferrin and Disodium Guanosine 5-Monophosphate (5'-GMP) designed to provide nutritional support for healthy bone remodeling and skeletal health.
LAFK9 may be used as supportive nutritional care for dogs and cats with osteoarthritis, hip dysplasia and fractures, under veterinary guidance. The formulation supports processes involved in bone formation and remodeling, including osteoblast and chondrocyte activity.
Key Features
Lactoferrin 100 mg per tablet
Disodium Guanosine 5-Monophosphate 10 mg per tablet
Supports bone remodeling and bone health
Supports joint and cartilage health
Nutritional support for osteoarthritis
Suitable for dogs and cats
Useful as supportive care for hip dysplasia and fractures
1 strip contains 10 tablets
Dosage
1 tablet per 10 kg body weight once daily, or as recommended by the veterinarian.
Safety / Important Information
For veterinary use in dogs and cats.
Use under veterinary guidance, particularly for pets with diagnosed joint or bone disorders.
Do not exceed the recommended dosage unless advised by a veterinarian.
This is a nutritional support product and should not replace treatment prescribed for the underlying condition.
Store according to the product label.
Keep out of reach of children.
Not for human use.